Annual ROE
-28.77%
-0.18%-0.63%
December 31, 2024
Summary
- As of February 20, 2025, MRNA annual return on equity is -28.77%, with the most recent change of -0.18% (-0.63%) on December 31, 2024.
- During the last 3 years, MRNA annual ROE has fallen by -174.85% (-119.69%).
- MRNA annual ROE is now -102.27% below its all-time high of 1268.82%, reached on December 1, 2015.
Performance
MRNA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-29.09%
-11.65%-66.80%
December 31, 2024
Summary
- As of February 20, 2025, MRNA quarterly return on equity is -29.09%, with the most recent change of -11.65% (-66.80%) on December 31, 2024.
- Over the past year, MRNA quarterly ROE has dropped by -0.43% (-1.50%).
- MRNA quarterly ROE is now -102.50% below its all-time high of 1161.81%, reached on September 1, 2009.
Performance
MRNA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MRNA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.6% | -1.5% |
| 3 y3 years | -119.7% | -1.5% |
| 5 y5 years | +24.3% | -1.5% |
MRNA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -119.7% | at low | -117.8% | +31.8% |
| 5 y | 5-year | -119.7% | +28.1% | -117.8% | +31.8% |
| alltime | all time | -102.3% | +94.7% | -102.5% | +98.2% |
Moderna ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | -28.77%(+0.6%) | -29.09%(+66.8%) |
| Sep 2024 | - | -17.44%(-59.1%) |
| Jun 2024 | - | -42.65%(+8.5%) |
| Mar 2024 | - | -39.30%(+37.1%) |
| Dec 2023 | -28.59%(-156.9%) | -28.66%(+42.9%) |
| Sep 2023 | - | -20.06%(-402.1%) |
| Jun 2023 | - | 6.64%(-74.7%) |
| Mar 2023 | - | 26.27%(-45.8%) |
| Dec 2022 | 50.27%(-65.6%) | 48.44%(-36.3%) |
| Sep 2022 | - | 76.08%(-28.5%) |
| Jun 2022 | - | 106.42%(-24.6%) |
| Mar 2022 | - | 141.06%(-13.6%) |
| Dec 2021 | 146.08%(-465.3%) | 163.25%(+20.2%) |
| Sep 2021 | - | 135.86%(+46.2%) |
| Jun 2021 | - | 92.90%(+327.1%) |
| Mar 2021 | - | 21.75%(-164.5%) |
| Dec 2020 | -39.99%(+5.2%) | -33.70%(+10.3%) |
| Sep 2020 | - | -30.55%(+4.7%) |
| Jun 2020 | - | -29.18%(-20.9%) |
| Mar 2020 | - | -36.88%(-3.3%) |
| Dec 2019 | -38.00%(+6.4%) | -38.12%(-4.8%) |
| Sep 2019 | - | -40.05%(-1.5%) |
| Jun 2019 | - | -40.66%(+6.9%) |
| Mar 2019 | - | -38.04%(+6.5%) |
| Dec 2018 | -35.70%(+2.3%) | -35.71%(-91.7%) |
| Sep 2018 | - | -429.65%(+36.9%) |
| Jun 2018 | - | -313.88%(-30.7%) |
| Mar 2018 | - | -452.65%(+62.9%) |
| Dec 2017 | -34.89%(-27.4%) | -277.89%(+81.4%) |
| Sep 2017 | - | -153.22%(+24.7%) |
| Jun 2017 | - | -122.89%(+44.2%) |
| Mar 2017 | - | -85.20%(+51.4%) |
| Dec 2016 | -48.09%(-103.8%) | - |
| Dec 2016 | - | -56.27%(-297.9%) |
| Sep 2016 | - | 28.44%(-90.3%) |
| Jun 2016 | - | 293.00%(-129.9%) |
| Mar 2016 | - | -980.38%(+361.5%) |
| Dec 2015 | 1268.82%(+756.3%) | -212.45%(-32.4%) |
| Sep 2015 | - | -314.37%(<-9900.0%) |
| Jun 2015 | - | 0.04%(-100.1%) |
| Mar 2015 | - | -56.00%(-154.4%) |
| Dec 2014 | 148.18%(+566.3%) | 102.88%(-49.7%) |
| Sep 2014 | - | 204.39%(+44.1%) |
| Jun 2014 | - | 141.86%(-30.1%) |
| Mar 2014 | - | 202.91%(+566.2%) |
| Dec 2013 | 22.24%(-86.9%) | 30.46%(-60.1%) |
| Sep 2013 | - | 76.25%(-29.5%) |
| Jun 2013 | - | 108.10%(+13.5%) |
| Mar 2013 | - | 95.25%(-67.2%) |
| Dec 2012 | 169.62%(-149.6%) | 290.02%(-120.9%) |
| Sep 2012 | - | -1389.91%(+190.0%) |
| Jun 2012 | - | -479.24%(+51.0%) |
| Mar 2012 | - | -317.42%(+48.2%) |
| Dec 2011 | -342.00%(-36.6%) | -214.21%(+50.9%) |
| Sep 2011 | - | -141.91%(-56.7%) |
| Jun 2011 | - | -327.55%(-79.5%) |
| Mar 2011 | - | -1601.52%(-279.4%) |
| Dec 2010 | -539.78%(-561.9%) | 892.67%(+259.6%) |
| Sep 2010 | - | 248.26%(+5.2%) |
| Jun 2010 | - | 236.04%(-42.9%) |
| Mar 2010 | - | 413.63%(+33.2%) |
| Dec 2009 | 116.85% | 310.60%(-73.3%) |
| Sep 2009 | - | 1161.81%(-292.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2009 | - | -604.48%(+66.4%) |
| Mar 2009 | - | -363.28%(+2.9%) |
| Dec 2008 | -329.36%(+159.6%) | -353.10%(+64.0%) |
| Sep 2008 | - | -215.31%(+41.5%) |
| Jun 2008 | - | -152.14%(+33.1%) |
| Mar 2008 | - | -114.30%(+17.9%) |
| Dec 2007 | -126.88%(+133.4%) | -96.96%(+7.3%) |
| Sep 2007 | - | -90.34%(+23.9%) |
| Jun 2007 | - | -72.94%(+35.3%) |
| Mar 2007 | - | -53.91%(+6.2%) |
| Dec 2006 | -54.35%(-3.9%) | -50.77%(+15.0%) |
| Sep 2006 | - | -44.16%(-5.8%) |
| Jun 2006 | - | -46.89%(-24.5%) |
| Mar 2006 | - | -62.07%(+6.1%) |
| Dec 2005 | -56.57%(-24.8%) | -58.48%(-8.2%) |
| Sep 2005 | - | -63.70%(-16.8%) |
| Jun 2005 | - | -76.56%(-16.5%) |
| Mar 2005 | - | -91.70%(-27.6%) |
| Dec 2004 | -75.23%(+366.4%) | -126.60%(-30.7%) |
| Sep 2004 | - | -182.65%(+18.0%) |
| Jun 2004 | - | -154.75%(+250.0%) |
| Mar 2004 | - | -44.21%(+210.9%) |
| Dec 2003 | -16.13%(-86.7%) | -14.22%(+0.1%) |
| Sep 2003 | - | -14.20%(-321.5%) |
| Jun 2003 | - | 6.41%(-105.8%) |
| Mar 2003 | - | -109.84%(+13.4%) |
| Dec 2002 | -121.67%(+52.0%) | -96.88%(+27.7%) |
| Sep 2002 | - | -75.89%(+11.5%) |
| Jun 2002 | - | -68.08%(-13.5%) |
| Mar 2002 | - | -78.72%(-7.4%) |
| Dec 2001 | -80.07%(+8.1%) | -85.02%(+17.4%) |
| Sep 2001 | - | -72.39%(-18.7%) |
| Jun 2001 | - | -89.00%(+5.8%) |
| Mar 2001 | - | -84.09%(+10.4%) |
| Dec 2000 | -74.08%(+85.6%) | -76.14%(-0.2%) |
| Sep 2000 | - | -76.27%(+41.5%) |
| Jun 2000 | - | -53.91%(+24.8%) |
| Mar 2000 | - | -43.21%(+11.2%) |
| Dec 1999 | -39.91%(+1017.9%) | -38.86%(+35.6%) |
| Sep 1999 | - | -28.66%(+42.5%) |
| Jun 1999 | - | -20.11%(+51.1%) |
| Mar 1999 | - | -13.31%(+243.9%) |
| Dec 1998 | -3.57%(-85.4%) | -3.87%(-40.6%) |
| Sep 1998 | - | -6.51%(-38.7%) |
| Jun 1998 | - | -10.62%(-27.1%) |
| Mar 1998 | - | -14.57%(-24.6%) |
| Dec 1997 | -24.52%(+495.1%) | -19.33%(+53.3%) |
| Sep 1997 | - | -12.61%(+126.8%) |
| Jun 1997 | - | -5.56%(+173.9%) |
| Mar 1997 | - | -2.03%(-221.6%) |
| Dec 1996 | -4.12%(-412.1%) | - |
| Sep 1996 | - | 1.67%(>+9900.0%) |
| Jun 1996 | 1.32%(-178.6%) | 0.00%(-100.0%) |
| Mar 1996 | - | -3.94%(-49.7%) |
| Dec 1995 | - | -7.84%(+103.1%) |
| Sep 1995 | - | -3.86%(+101.0%) |
| Jun 1995 | -1.68%(-136.1%) | -1.92%(-142.0%) |
| Mar 1995 | - | 4.57%(-1.1%) |
| Dec 1994 | - | 4.62%(-1.3%) |
| Sep 1994 | - | 4.68%(-52.4%) |
| Jun 1994 | 4.65% | 9.84%(+29.6%) |
| Mar 1994 | - | 7.59%(-29.8%) |
| Dec 1993 | - | 10.81%(-127.0%) |
| Sep 1993 | - | -40.00% |
FAQ
- What is Moderna annual return on equity?
- What is the all time high annual ROE for Moderna?
- What is Moderna annual ROE year-on-year change?
- What is Moderna quarterly return on equity?
- What is the all time high quarterly ROE for Moderna?
- What is Moderna quarterly ROE year-on-year change?
What is Moderna annual return on equity?
The current annual ROE of MRNA is -28.77%
What is the all time high annual ROE for Moderna?
Moderna all-time high annual return on equity is 1268.82%
What is Moderna annual ROE year-on-year change?
Over the past year, MRNA annual return on equity has changed by -0.18% (-0.63%)
What is Moderna quarterly return on equity?
The current quarterly ROE of MRNA is -29.09%
What is the all time high quarterly ROE for Moderna?
Moderna all-time high quarterly return on equity is 1161.81%
What is Moderna quarterly ROE year-on-year change?
Over the past year, MRNA quarterly return on equity has changed by -0.43% (-1.50%)